ACRF Drug Discovery Centre

Therapeutic Approaches: Small Molecules, , Covid-19

Therapeutic Areas of Expertise: Immunology, Metabolic Disorders, Oncology

Center/Program Highlights:

ACRF funds were awarded to create an integrated and dedicated Drug Discovery Centre for Childhood Cancer, focusing specifically on defined molecular targets for improved treatment of childhood cancer.

The project aimed to identify and validate bona fide molecular targets in various forms of childhood cancer. ACRF funding provided all necessary scientific equipment and instrumentation to fully fit-out the ACRF Drug Discovery Centre for Childhood Cancer.

Researchers have used a combined approach aimed at first defining novel targets in specific pathways required by the cancer cell, and, second, using this information to design and test large-scale, small molecule screening strategies in a drug discovery process.

This $3.1 million grant offered by the ACRF has been made possible through a generous bequest by the Estate of the late Mrs Berenice M McDonnell.

Sources of Funding: Philanthropy, Industry Partnerships, Disease Foundations, University, Revenue, Federal/State,


Institutional Affiliation(s): Children's Cancer Institute Australia for Medical Research

PO Box 81
NSW, 2031

Center/Program Start Date: 2010

Number of Employees: 3